angiotensin ii, des-phe(8)- has been researched along with Venous Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alenina, N; Bader, M; Costa-Fraga, FP; De Sousa, FB; Fraga-Silva, RA; Santos, RA; Sinisterra, RD | 1 |
| Buczko, W; Kucharewicz, I; Matys, T; Pawlak, D; Pawlak, R | 1 |
| Buczko, W; Chabielska, E; Kucharewicz, I; Matys, T; Pawlak, D; Rólkowski, R | 1 |
3 other study(ies) available for angiotensin ii, des-phe(8)- and Venous Thrombosis
| Article | Year |
|---|---|
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.
Topics: Angiotensin I; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Rats; Rats, Inbred SHR; Venous Thrombosis | 2011 |
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Hypertension, Renal; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Venous Thrombosis | 2002 |
The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Collagen; Fibrinolytic Agents; Hemostasis; Losartan; Male; Peptide Fragments; Platelet Adhesiveness; Rats; Rats, Inbred SHR; Rats, Wistar; Venous Thrombosis | 2000 |